mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.002 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.002 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.002 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.003 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.003 |